Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FG1NN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,237
Award facts
- Contract value 100% obligated
- $16,237.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,237.33 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 ml pen injectors. This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by May 1, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The company's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs. Dupixent is a prescription biologic treatment commonly used for atopic dermatitis, asthma, and chronic rhinosinusitis, making this delivery order consistent with the company's established portfolio of specialty pharmaceutical products supplied to Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FG1NN?
SPE2DB25FG1NN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 30, 2025.
How much is contract SPE2DB25FG1NN worth?
The government has obligated $16,237 on SPE2DB25FG1NN.
Is contract SPE2DB25FG1NN an order under another contract?
Yes. SPE2DB25FG1NN is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG1NN competed?
The extent of competition for SPE2DB25FG1NN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award